| Fiscal Period | 2026 | 2025 | 2024 | 2023 |
|---|---|---|---|---|
| Period End Date | Mar 26 | Mar 25 | Mar 24 | Mar 23 |
| Total Operating Expense | 23,724.07 | 21,391.03 | 20,714.98 | 19,047.03 |
| Other Net | 263.77 | 38.94 | 33.33 | 33.84 |
| Diluted Weighted Average Shares | 80.82 | 80.82 | 80.73 | 80.76 |
| Gain( Loss)on Saleof Assets | 31.81 | -5.06 | 3.49 | 1.58 |
| Depreciation/ Amortization | 1,082.60 | 993.38 | 939.10 | 1,017.83 |
| Operating Income | 4,438.52 | 6,156.59 | 5,059.11 | 3,706.09 |
| Net Income | 3,879.23 | 5,272.52 | 4,121.55 | 2,801.91 |
| Income Availableto Com Excl Extra Ord | 3,879.23 | 5,272.52 | 4,121.55 | 2,801.91 |
| Other Operating Expenses Total | 795.71 | 623.92 | 649.33 | 511.60 |
| Net Income Before Taxes | 5,223.63 | 6,820.81 | 5,701.90 | 4,038.35 |
| Minority Interest | 17.49 | 3.32 | -32.17 | -30.98 |
| Interest Exp( Inc) Net- Operating Total | 1.02 | 2.07 | 2.51 | 1.36 |
| Net Income After Taxes | 3,869.79 | 5,291.05 | 4,155.31 | 2,835.49 |
| Income Availableto Com Incl Extra Ord | 3,879.23 | 5,272.52 | 4,121.55 | 2,801.91 |
| Costof Revenue Total | 10,868.88 | 10,159.92 | 9,957.22 | 9,314.24 |
| Gross Profit | 17,293.71 | 17,387.70 | 15,816.87 | 13,438.88 |
| Interest Inc( Exp) Net- Non- Op Total | 489.53 | 630.34 | 605.97 | 296.84 |
| Unusual Expense( Income) | 409.69 | -9.60 | 303.30 | 309.57 |
| Diluted Net Income | 3,879.23 | 5,272.52 | 4,121.55 | 2,801.91 |
| DPS- Common Stock Primary Issue | 13.00 | 13.00 | 13.00 | 8.50 |
| Provisionfor Income Taxes | 1,353.84 | 1,529.76 | 1,546.59 | 1,202.86 |
| Equity In Affiliates | -8.05 | -21.85 | -1.59 | -2.60 |
| period Type | - | - | - | - |
| Net Income Before Extra Items | 3,879.23 | 5,272.52 | 4,121.55 | 2,801.91 |
| Total Revenue | 28,162.59 | 27,547.62 | 25,774.09 | 22,753.12 |
| period Length | 12.00 | 12.00 | 12.00 | 12.00 |
| Revenue | 28,162.59 | 27,547.62 | 25,774.09 | 22,753.12 |
| Selling/ General/ Admin Expenses Total | 10,045.05 | 9,245.18 | 8,433.06 | 7,507.04 |
| Diluted Normalized EPS | 51.46 | 65.19 | 53.76 | 37.37 |
| Research Development | 521.12 | 376.16 | 430.46 | 385.39 |
| Diluted EPS Excluding Extra Ord Items | 48.00 | 65.24 | 51.05 | 34.69 |
Cipla Dividend Cipla Bonus Cipla News Cipla AGM Cipla Rights Cipla Splits Cipla Board Meetings Cipla Key Metrics Cipla Shareholdings Cipla Balance Sheet Cipla Cashflow Cipla Q1 Results Cipla Q2 Results Cipla Q3 Results Cipla Q4 Results
Top GainersTop LosersIndian IndicesBSE Active StocksNSE Active Stocks
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.